Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

128.75 -2.29 (-1.75%)
Streaming Delayed Price Updated: 10:28 AM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
2 Market-Moving Stocks You Can't Afford to Ignore
Friday's market action saw volatility both upward and downward. 
Via The Motley Fool
US Stocks Mostly Higher; Dow Surges 300 Points
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday. 
Via Benzinga
Dialysis Provider DaVita Slashes FY22 Earnings Outlook Citing Continued Pandemic Impact, Shares Fall
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
Recap: DaVita Q3 Earnings
DaVita (NYSE:DVA) reported its Q3 earnings results on Friday, October 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by... 
Via Benzinga
What 4 Analyst Ratings Have To Say About DaVita
Analysts have provided the following ratings for DaVita (NYSE:DVA) within the last quarter: 
Via Benzinga
Warren Buffett Stocks: DaVita Inc.
At the end of the first quarter, Berkshire owned a staggering 38% of DaVita’s total shares outstanding. That sort of conviction is difficult to ignore, especially from a legend like Buffett. 
Via Talk Markets
Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate
 
Via Benzinga
Earnings Scheduled For October 28, 2022
Companies Reporting Before The Bell • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million. 
Via Benzinga
DaVita's Earnings: A Preview
DaVita (NYSE:DVA) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that DaVita will report an... 
Via Benzinga
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term. 
Via InvestorPlace
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick? 
Via TheNewswire.com
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?  
Via Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy Now
Here are some of the most undervalued mid-cap stocks to buy now. 
Via InvestorPlace
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
From Federman & Sherwood
Via Business Wire
7 Undervalued Stocks That Everyone Is Missing Out On
All of these undervalued stocks have above-average free cash flow yields and should rebound in the longer term. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
Upgrades 
Via Benzinga
Meta Platforms Price Target Cut By This Analyst, Plus BMO Capital Predicts $223 For Salesforce
Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading. 
Via Benzinga
Recap: DaVita Q2 Earnings
DaVita (NYSE:DVA) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 10.05%,... 
Via Benzinga
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter. 
Via Benzinga
Addus HomeCare's Earnings: A Preview
Addus HomeCare (NASDAQ:DVA) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Addus HomeCare... 
Via Benzinga
Why Shares Of DaVita Are Down Today
Shares of DaVita Inc. (NYSE: DVA) are trading lower today in sympathy Fresenius Medical Care AG & Co (NYSE: FMS), which provided a bearish 2022 outlook and withdrew its 2025 targets.  
Via Benzinga
12 Stocks Investors Want To See
A look at some very inexpensive growth stocks and a few inexpensive dividend growth stocks. 
Via Talk Markets
6 Stocks Insiders Are Buying Now
These are 6 stocks insiders are buying now. Execs buying shares now want to get in before Q2 earnings come out - a good sign for investors. 
Via InvestorPlace
$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying
Although US stocks closed slightly lower on Monday, there were a few notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
7 Dividend Stocks to Buy and Hold Forever
Despite rising interest rates, investors continue to like dividend-paying stocks. Here are seven dividend stocks to buy and hold forever. 
Via InvestorPlace
Stock Market Rallies As Fed Chief Powell Vows 'Unconditional' Inflation Fight: Weekly Review
Stocks rebounded this week, with China EV stocks and medicals among the leaders. 
Via Investor's Business Daily
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
67 Biggest Movers From Yesterday
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.